NOV NOV
Company Profile ↓Company Overview
NOV (NOV) is a publicly traded company listed on with a market capitalization of $7.04B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.37.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $8.74B (-1.4% YoY); net profit $145.00M.
- Trailing 12 Months Year-on-year growth — revenue -1.4%, earnings -77.2%.
- 5-Year Trend Long-term compounding — revenue CAGR -0.6%, profit CAGR -11.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -0.63% |
| 1 Year: | -1.42% |
Compounded Profit Growth
| 5 Years: | -11.61% |
| 1 Year: | -77.17% |
Stock Price Performance
| 1 Year: | +63.43% |
| 6 Months: | +5.31% |
| 3 Months: | -2.23% |
| 1 Month: | +6.67% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)49.42 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -0.6% CAGR over 5 years.
- Earnings shrank at -11.6% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 1.74B | 1.76B | 1.83B | 1.97B | 1.79B | 2.11B | 2.15B | 2.40B | 1.94B | 2.13B | 2.13B | 2.28B | 1.88B | 1.50B | 1.38B | 1.25B | 1.42B | 1.34B | 1.55B | 1.73B | 1.89B | 1.96B | 2.09B | 2.19B | 2.15B | 2.22B | 2.19B | 2.10B | 2.19B | 2.18B | 2.28B | 2.05B | 2.13B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.74B | 1.76B | 1.81B | 1.67B | 1.61B |
| Gross Profit | 855.00M | 672.00M | 359.00M | 244.00M | 35.00M | 79.00M | -459.00M | 209.00M | 231.00M | 285.00M | 167.00M | 287.00M | 355.00M | 393.00M | 409.00M | 256.00M | 62.00M | 151.00M | 376.00M | 224.00M | 137.00M | 139.00M | 156.00M | 231.00M | 185.00M | 214.00M | 309.00M | 368.00M | 411.00M | 457.00M | 468.00M | 458.00M | 590.00M | 469.00M | 447.00M | 446.00M | 412.00M | 462.00M | 379.00M | 521.00M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 303.00M | 305.00M | 300.00M | 332.00M | 328.00M |
| Operating Income | 438.00M | 234.00M | - | -189.00M | -270.00M | -1.19B | - | -97.00M | -62.00M | -7.00M | - | -1.00M | 52.00M | 73.00M | - | -48.00M | -5.73B | -154.00M | - | -1.95B | -100.00M | -74.00M | -88.00M | 12.00M | -43.00M | -21.00M | 68.00M | 55.00M | 126.00M | 181.00M | 183.00M | 162.00M | 313.00M | 194.00M | 152.00M | 143.00M | 107.00M | 162.00M | 47.00M | 193.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 224.00M | 184.00M | 178.00M | 149.00M | 271.00M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.00M | 22.00M | 22.00M | 22.00M | 21.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 115.00M | 73.00M | 66.00M | 35.00M | 157.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00M | 29.00M | 147.00M | 15.00M | 41.00M |
| Net Income | 289.00M | 155.00M | -1.52B | -119.00M | -217.00M | -1.36B | -714.00M | -122.00M | -75.00M | -26.00M | -14.00M | -68.00M | 24.00M | 1.00M | 12.00M | -77.00M | -5.39B | -244.00M | -385.00M | -2.05B | -93.00M | -55.00M | -115.00M | -26.00M | -69.00M | -50.00M | 69.00M | 32.00M | 126.00M | 155.00M | 114.00M | 119.00M | 226.00M | 130.00M | 73.00M | 108.00M | 42.00M | -78.00M | 19.00M | 112.00M |
| Diluted EPS | 0.74 | 0.41 | -4.06 | -0.32 | -0.58 | -3.62 | -1.90 | -0.32 | -0.20 | -0.07 | -0.04 | -0.18 | 0.06 | 0.00 | 0.03 | -0.20 | -14.11 | -0.64 | -1.01 | -5.34 | -0.24 | -0.14 | -0.30 | -0.07 | -0.18 | -0.13 | 0.18 | 0.08 | 0.32 | 0.39 | 0.29 | 0.30 | 0.57 | 0.33 | 0.19 | 0.29 | 0.11 | -0.21 | 0.05 | 0.31 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.79B | 13.43B | 12.71B | 12.16B | 14.66B | 17.19B | 19.22B | 21.44B | 14.76B | 7.25B | 7.30B | 8.45B | 8.48B | 6.09B | 5.52B | 7.24B | 8.58B | 8.87B | 8.74B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.90B | 6.75B | 6.86B | 6.98B |
| Gross Profit | 2.83B | 4.07B | 3.78B | 3.83B | 4.50B | 5.04B | 5.10B | 5.81B | 3.06B | -101.00M | 892.00M | 1.44B | 845.00M | 434.00M | 774.00M | 1.33B | 1.83B | 2.01B | 1.77B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07B | 1.18B | 1.13B | 1.20B |
| Operating Income | 2.04B | 2.92B | 2.31B | 2.45B | 2.94B | 3.39B | 3.20B | 3.61B | -390.00M | -2.41B | -277.00M | 211.00M | -6.28B | -2.42B | -134.00M | 264.00M | 651.00M | 876.00M | 564.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 617.00M | 1.00B | 1.26B | 818.00M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 78.00M | 88.00M | 91.00M | 88.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 238.00M | 612.00M | 831.00M | 375.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 83.00M | -373.00M | 196.00M | 224.00M |
| Net Income | 1.34B | 1.95B | 1.47B | 1.67B | 1.99B | 2.49B | 2.33B | 2.50B | -769.00M | -2.41B | -237.00M | -31.00M | -6.09B | -2.54B | -250.00M | 155.00M | 993.00M | 635.00M | 145.00M |
| Diluted EPS | 3.76 | 4.90 | 3.52 | 3.98 | 4.70 | 5.83 | 5.44 | 5.82 | -1.99 | -6.41 | -0.63 | -0.08 | -15.96 | -6.62 | -0.65 | 0.39 | 2.50 | 1.60 | 0.39 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 21.48B | 21.53B | 23.05B | 25.52B | 31.48B | 34.81B | 33.56B | 25.97B | 21.14B | 20.21B | 19.80B | 13.15B | 9.93B | - | 10.13B | 11.29B | 11.36B | 11.29B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.49B | 5.84B | 5.77B | 5.82B |
| Cash & Equivalents | 957.00M | 1.84B | 1.54B | 2.62B | 3.33B | 3.54B | 3.32B | 3.44B | 3.54B | 2.08B | 1.41B | 1.44B | 1.43B | 1.17B | 1.69B | - | 1.07B | 816.00M | 1.23B | 1.55B |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.81B | 2.15B | 1.93B | 1.80B |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.74B | 1.91B | 1.82B | 1.70B |
| Total Liabilities | - | - | 8.76B | 7.30B | 7.19B | 7.79B | 11.13B | 12.48B | 12.79B | 9.51B | 7.14B | 6.05B | 5.91B | 5.30B | 4.65B | - | 5.00B | 5.05B | 4.93B | 4.97B |
| Current Liabilities | - | - | 5.62B | 4.51B | 4.54B | 5.42B | 5.65B | 6.68B | 7.37B | 3.96B | 3.05B | 2.35B | 2.34B | 2.25B | 1.87B | - | 2.44B | 2.44B | 2.35B | 2.41B |
| Long Term Debt | - | - | 870.00M | 876.00M | 514.00M | 159.00M | 3.15B | 3.15B | 3.01B | 3.91B | 2.71B | 2.71B | 2.48B | 1.99B | 1.83B | - | 1.72B | 1.71B | 1.70B | 1.69B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.37B | 2.38B | 2.39B | 2.34B |
| Total Equity | 5.06B | 6.72B | 12.63B | 14.11B | 15.75B | 17.62B | 20.24B | 22.23B | 20.69B | 16.38B | 13.94B | 14.09B | 13.82B | 7.78B | 5.21B | - | 5.10B | 6.17B | 6.38B | 6.27B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 392.83M | 393.95M | 381.55M | 360.80M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.19B | 2.29B | 2.10B | 1.54B | 2.14B | 620.00M | 3.40B | 2.61B | 1.33B | 960.00M | 832.00M | 521.00M | 714.00M | 926.00M | - | -179.00M | 143.00M | 1.30B | 1.25B |
| Investing Cash Flow | -575.00M | -2.47B | -552.00M | -743.00M | -1.46B | -3.43B | -2.96B | -1.10B | -514.00M | -488.00M | -245.00M | -457.00M | -315.00M | -144.00M | - | -238.00M | -293.00M | -471.00M | -362.00M |
| Financing Cash Flow | 150.00M | -74.00M | -491.00M | -102.00M | -464.00M | 2.58B | -305.00M | -1.34B | -2.16B | -1.14B | -595.00M | -30.00M | -647.00M | -259.00M | - | -96.00M | -103.00M | -406.00M | -584.00M |
| Capital Expenditure | -252.00M | -379.00M | -250.00M | -232.00M | -483.00M | -569.00M | -614.00M | -699.00M | -453.00M | -284.00M | -192.00M | -244.00M | -233.00M | -226.00M | - | -214.00M | -283.00M | -351.00M | -375.00M |
| Free Cash Flow | 936.00M | 1.92B | 1.84B | 1.31B | 1.66B | 51.00M | 2.78B | 1.92B | 879.00M | 676.00M | 640.00M | 277.00M | 481.00M | 700.00M | - | -393.00M | -140.00M | 953.00M | 876.00M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -513.00M | -253.00M | 427.00M | 305.00M |
| Share Buybacks | - | - | - | - | - | - | - | 779.00M | 2.22B | - | - | - | - | - | - | - | - | 229.00M | 315.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 28.9% | 30.3% | 29.8% | 31.5% | 30.7% | 29.3% | 26.6% | 27.1% | 20.8% | -1.4% | 12.2% | 17.1% | 10.0% | 7.1% | 14.0% | 18.4% | 21.4% | 22.7% | 20.2% |
| Operating Margin % | 20.9% | 21.7% | 18.2% | 20.1% | 20.0% | 19.7% | 16.6% | 16.9% | -2.6% | -33.3% | -3.8% | 2.5% | -74.1% | -39.8% | -2.4% | 3.6% | 7.6% | 9.9% | 6.5% |
| Net Margin % | 13.7% | 14.5% | 11.6% | 13.7% | 13.6% | 14.5% | 12.1% | 11.7% | -5.2% | -33.3% | -3.2% | -0.4% | -71.9% | -41.7% | -4.5% | 2.1% | 11.6% | 7.2% | 1.7% |
| ROE % | 19.9% | 15.5% | 10.4% | 10.6% | 11.3% | 12.3% | 10.5% | 12.1% | -4.7% | -17.3% | -1.7% | -0.2% | -78.4% | -48.8% | - | 3.0% | 16.1% | 10.0% | 2.3% |
| ROCE % | - | 18.4% | 13.6% | 13.2% | 14.6% | 13.1% | 11.4% | 13.8% | -1.8% | -13.3% | -1.6% | 1.2% | -57.6% | -30.1% | - | 3.4% | 7.3% | 9.7% | 6.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NOV
NOV (NOV) Stock Still Looks Undervalued Despite Its 64% Run - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPTGx6bXh2S2I1ODRvRUVCZG5nSkFuVWJnZ0NCU09DUXU2c0tQMGNZaWM2T2s5bFUxODE3UmJmalVXbFRVSGFGWVJ0N3ZNTTFiTkh3X0ZjY3hhZlozWW81ek5uQ25tRXBiR1NNVGh2b3RxNnNSZ0lVakN0X2QxQmFsSG0xNnRFbU5qdUlZN1…
Insider Sale: Director at $NOV Sells 9,594 Shares - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxON1IwZV9MZ1Y0VXNEYUZ4MUFJMFdxN2twT0ZNaDBVeHlyRVlyTWtrT3RTeTVBMkJaYXRCR19sN2ZpNGVZVHJwU2VMdTEtUjYzZ2RzQUU1a3hSbkFUaW80MVVJRFM2a3FpcVhlb0NRYW5SOTRFN0dMaXdGMjV4OGJSZ3JDTjZ3OXIyeVlIRU…
NOV Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxQTnZPTUhTc0NWV1pSNG14U1ZfZmxtVmVFcEpFSjRmZWxxSFFRZXpCNnJBcVduRU5vQUp5cEgzQ3JMWEdDWXdnbGRiXzFmUDlZRzQ2dG5tMFJWMUpsVFNidkRsVU9SekpKUVV4X3QyZUZneE50Rmd0R01YdmFmZXNOMjg4T1JoRkp4OVFybT…
NOV Inc. (NYSE: NOV) director sells 9,594 shares at $19.21 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOY1pYQ2Y4YXRCN05KTmNBQUROdUVnRjIwQ2hGel9Vc3dpVG14VGNWS1hKVk1CR2JtcDh3UVRNeUpmak82VEZPLUd0czFfVVJQMFdST0RMdWlSdjlROUllN014U054THBzaEE3aTVyTm1hcUtWamIzY3VTdkgxR0ZEYUV6SHQ4RUFMdDZaST…
An 8-Day Winning Streak Has NOV Stock Up 9.5% - Trefis
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxONWpuNjgwaWpHLVBrWUV0SGJ1LVRVbnlnRXllelY5WUE3VWxPeVRMc0U2ZVZyYUxQN0Z2Xzc3azEtM0pFUjFOOTY4SkxaMGdST1pUb1pUWW8xLW1UM1phckFpemNISG8yRkJfRkZybTIxVFpCTXRuaVNpZjZqZzM3YzFfRzJnM0JqS1RGZl…
NOV (NOV) Stock Price Drops As Margin Gains Meet Cash Flow Doubts - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNaW9TMzhiMGY2WW9xdVpwZHVtMmNvMUFqbzZNOE81b09fSl80OUVvdnBfTDZERzNSdnhJWGFqc1d2dl91SUZSUDNreHZqcDZmZVdES1BLbjNsd0ZJbHhweDRsSnhjVnpsdzdDeV9PcldzWVV3WGdJUlFyMXBwN2FVY3g2NkRzNk9OUEhRbH…
NOV — Frequently Asked Questions
What is the current share price of NOV?
As of 2026-08-05 17:25 PDT, NOV trades at $19.50 on NASDAQ/NYSE. Its 52-week range is $11.60 to $21.36.
What is the market capitalisation of NOV?
NOV has a market capitalisation of $7.04B on NASDAQ/NYSE.
What is the P/E ratio of NOV?
NOV trades at a trailing price-to-earnings (P/E) ratio of 50.00. Its price-to-book (P/B) ratio is 1.12.
What is the return on equity (ROE) of NOV?
NOV has a return on equity (ROE) of 2.31%. Its return on capital employed (ROCE) is 6.35%.
Is NOV a good stock to buy?
This page provides a data-driven analysis of NOV, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.